Updates in non-small cell lung cancer
Updates in non-small cell lung cancer
复制标题
DOI：
10.1188/08.cjon.587-596
复制
发表时间：
2008-08-01
影响因子：
1.1
通讯作者：
Walker, Suzanne
中科院分区：
文献类型：
--
作者：
Walker, Suzanne
肺癌是男性和女性癌症死亡的主要原因。非小细胞肺癌（NSCLC）是最常见的肺癌类型，占肺癌诊断的80%以上。五年生存率仍为15%，但预防、早期发现和治疗的新策略可能会提高生存率。本文概述了NSCLC的最新进展，重点是治疗策略的进展。新的靶向治疗，以及遗传蓝图的进展，将被讨论。护士在NSCLC患者的评估和管理中发挥着关键作用，因此，必须了解最新的预防，筛查和治疗方案。
Lung cancer is the leading cause of cancer death in both men and women. Non-small cell lung cancer (NSCLC) is the most common type of lung cancer, representing more than 80% of lung cancer diagnoses. Five-year survival remains at 15%, but new strategies for prevention, early detection, and treatment may improve survival rates. This article provides an overview of updates in NSCLC, with an emphasis on advances in treatment strategies. Newer targeted therapies, as well as advances in genetic blueprinting, will be discussed. Nurses play a pivotal role in the assessment and management of patients with NSCLC and, therefore, must remain abreast of the most current prevention, screening, and treatment options.